Hepatoprotective effects of l-carnitine against cyclosporine A-induced liver injury in white albino rats; a newly proposed mechanism of action
Journal Title: International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP) - Year 2016, Vol 5, Issue 3
Abstract
It is well documented that l-carnitine (L-C) has protective effects against various types of injury. Although its antioxidant action has been reported as a major mechanism, other suggested pathways may be implicated in its protective effect. This study was designed to evaluate the suggested pathways which may be implicated in the protective effect of L-C on liver injury caused by cyclosporine A (CsA). Forty-two adult male Swiss albino rats weighing 180–200 g were assigned randomly into 6 groups, 7 rats each: rats were given i.p. either sterile saline (1 ml/kg/d), L-C (50 or 200 mg/kg/d), CsA (15 mg/kg/d), or a combination of CsA and L-C for 4 weeks. The impact of L-C on the hepatic injury was assessed by estimation of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin (T.Bil). Superoxide dismutase (SOD), glutathione reductase (GSH-Rd), malondialdehyde (MDA) levels were measured in both serum and liver homogenates. In addition, prostaglandin E2 (PGE2) and nitric oxide (NO) were estimated in liver homogenates. CsA treatment caused liver dysfunction, manifested by elevation in serum AST, ALT, and T.Bil levels, and associated with elevation in MDA and reduction in SOD, GSH-Rd, PGE2, and NO levels in serum and liver homogenates. Concomitant administration of L-C induced dose-dependent improvement of liver functions, antioxidant enzymes, and MDA levels. Furthermore, the administration of L-C at a high dose ameliorated the hepatic levels of PGE2 and NO. These findings suggest that L-C has a protective effect against CsA-induced liver injury not only by its antioxidant properties but also, by its effect on PGE2 and NO pathways.
Authors and Affiliations
Sanaa. A. Ahmed
Keywords
Related Articles
- EP ID EP408542
- DOI -
- Views 101
- Downloads 0
A review on ethanobotanical uses and pharmacology of plecospermum spinosum
The association of humans and animals with plants obviously originated with the beginning of life on earth, when plants supplied much of the shelter, oxygen, food and medicine needed by higher life forms. Overtime and wi...
Hypolipidemic changes in Kanakalinga karpoorati mezhugu therapy in Experimental hypothyroid disorder
Kanaka linga karpoorathi mezhugu is a herbomineral drug preparation used in Siddha system of medicine used to treat thyroid disorders and allied ailments. Known risk factors for thyroid disease include autoimmunity, ext...
Drug utilization study in post cataract surgery patients in a tertiary care hospital
Background Cataract is the major preventable cause of blindness. In India 50-80% of blindness is due to cataract. Recent data from World Health Organization (WHO) shows 25% decrease in blindness prevalence in India. Cat...
Computational and molecular designing studies of novel flavonoid analogues as HMG CoA Reductase and cholesterol esterase inhibitors for their Cardioprotective effect using in Silico docking studies
The objective of the study was to generate a series of pharmacophores from a parent flavone skeleton and evaluate their in silico HMG CoA reductase and cholesterol esterase enzyme inhibitory potential using the software...
Protective effect of Cardiospermum halicacabum on potassium dichromate induced nephrotoxicity in rats
Potassium dichromate is a chemical compound widely used in metallurgy, chrome plating, chemical industry, textile manufacture, wood preservation, photography, photoengraving, refractory, stainless steel industries and...